Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine-Reference-Cited by-同舟云学术

Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine

Published:2015-06 Issue:6 Volume:21 Page:607.e1-607.e8
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Theys K.,Camacho R.J.,Gomes P.,Vandamme A.M.,Rhee S.Y.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference29 articles.

1. for ECHO Study Group. Rilpivirine vs. efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial;Molina;Lancet,2011

2. Rilpivirine vs. efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV (THRIVE): a phase 3, randomised, non-inferiority trial;Cohen;Lancet,2011

3. EDURANT (rilpivirine) package insert. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002264/WC500118874.pdf. [Accessed 12.03.14].

4. Pre-existing mutations in the rilpivirine phase III trials ECHO and THRIVE: prevalence and impact on virologic response;Vingerhoets;Antivir Ther,2013

5. Genotypic and phenotypic characterization of HIV-1 isolates obtained from patients on rilpivirine therapy experiencing virologic failure in the phase 3 ECHO and THRIVE studies: 48-week analysis;Rimsky;J Acquir Immune Defic Syndr,2012

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan;Viruses;2024-06-14

2. Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria;Journal of Antimicrobial Chemotherapy;2021-11-06

3. Low prevalence of doravirine-associated resistance mutations among polish human immunodeficiency-1 (HIV-1)–infected patients;Antiviral Therapy;2021-05

4. Avoiding Drug Resistance in HIV Reverse Transcriptase;Chemical Reviews;2021-01-28

5. Choosing appropriate pharmacotherapy for drug-resistant HIV;Expert Opinion on Pharmacotherapy;2019-01-24